稳心颗粒联合瑞舒伐他汀对老年冠心病患者血管内皮功能及心功能指标的影响

2021-03-25 22:28:36叶维聪莫振兆张日超李周安胡荣权林振
中国医学创新 2021年23期
关键词:心功能

叶维聪 莫振兆 张日超 李周安 胡荣权 林振

【摘要】 目的:探討稳心颗粒联合瑞舒伐他汀治疗老年冠心病的临床效果及对心功能、不良反应的影响。方法:选取本院2017年10月-2019年10月收治的86例老年冠心病患者,按随机数字表法分为对照组和观察组,各43例。对照组采用瑞舒伐他汀治疗,观察组在对照组基础上加用稳心颗粒治疗。比较两组血管内皮功能、心功能及不良反应发生情况。结果:两组治疗前血管内皮功能、心功能指标相比,差异均无统计学意义(P>0.05);观察组治疗后ET-1、VEGF水平分别为(72.19±6.28)pg/L、(74.58±8.27)ng/L,均低于对照组的(80.34±7.21)pg/L、(81.36±8.41)ng/L,NO水平为(70.14±7.59)μmol/L,高于对照组的(63.45±7.13)μmol/L,差异均有统计学意义(P<0.05);观察组治疗后LVEF、CI水平分别为(57.19±6.74)%、(3.42±0.49)L/(min·m2),均高于对照组的(49.36±6.42)%、(2.93±0.45)L/(min·m),LVED-VI水平为(70.21±5.46)mL/m,低于对照组的(78.52±5.63)mL/m,差异均有统计学意义(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:联用稳心颗粒与瑞舒伐他汀可改善老年冠心病患者血管内皮功能,缓解心肌缺血现象,促进心功能恢复,安全可靠,值得临床广泛应用。

【关键词】 老年冠心病 稳心颗粒 瑞舒伐他汀 血管内皮功能 心功能 不良反应

Effect of Wenxin Granules Combined with Rosuvastatin on Vascular Endothelial Function and Cardiac Function Indexes in Elderly Patients with Coronary Heart Disease/YE Weicong, MO Zhenzhao, ZHANG Richao, LI Zhouan, HU Rongquan, LIN Zhen. //Medical Innovation of China, 2021, 18(23): 0-060

[Abstract] Objective: To investigate the effect of Wenxin Granules combined with Rosuvastatin in the treatment of elderly coronary heart disease on vascular endothelial function, cardiac function and adverse reactions. Method: A total of 86 elderly patients with coronary heart disease who were admitted to our hospital from October 2017 to October 2019 were selected, they were divided into the control group and the observation group, according to the random number table method, with 43 cases in each group. The control group was treated with Rosuvastatin, and the observation group was treated with Wenxin Granules on the basis of the control group. The vascular endothelial function, cardiac function indexes and adverse reactions were compared between the two groups. Result: There were no significant differences in vascular endothelial function and cardiac function indexes between the two groups before treatment (P>0.05); the levels of ET-1 and VEGF in the observation group after treatment were (72.19±6.28) pg/L,

(74.58±8.27) ng/L, lower than (80.34±7.21) pg/L, (81.36±8.41) ng/L of the control group, the NO level was (70.14±7.59) μmol/L, higher than (63.45±7.13) μmol/L of the control group, the differences were statistically significant (P<0.05); after treatment, the LVEF and CI levels of the observation group were (57.19±6.74) %, (3.42±0.49) L/(min·m2), higher than (49.36±6.42)%, (2.93±0.45) L/(min·m2) of the control group, LVED-VI

level was (70.21±5.46) mL/m2, lower than (78.52±5.63) mL/m2 of the control group, the differences were statistically significant (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion: Combined use of Wenxin Granules and Rosuvastatin can improve vascular endothelial function, relieve myocardial ischemia and promote the recovery of cardiac function in elderly patients with coronary heart disease, it is safe and reliable, and worthy of widespread clinical application.

[Key words] Elderly coronary heart disease Wenxin Granules Rosuvastatin Vascular endothelial function Heart function Adverse reactions

First-author’s address: Southwest Hospital of Zhanjiang, Zhanjiang 524500, China

doi:10.3969/j.issn.1674-4985.2021.23.014

冠心病多由冠脉狭窄或闭塞引起,患者心前区可出现发作性绞痛,严重影响身心健康[1]。临床认为,血脂异常是动脉粥样硬化的重要诱因,故予以降脂治疗是改善老年冠心病的关键[2]。瑞舒伐他汀属于强效降脂药物,可有效降低血脂水平,改善血液流速,并可稳定斑块,延缓其进展,从而缓解临床症状[3]。但老年患者合并症多,在降脂的同时需考虑其他疾病因素,单药治疗不利于病情稳定。……

登录APP查看全文

猜你喜欢
心功能
老年心力衰竭患者BNP及乳酸水平与心功能的相关性
慢性阻塞性肺疾病合并右心功能不全的研究进展
血浆corin、NEP、BNP与心功能衰竭及左室收缩功能的相关性
心功能如何分级?
心功能不全透析患者检测纤维蛋白单体的临床意义
中西医结合治疗舒张性心功能不全临床观察
磷酸肌酸钠用于老年冠心病合并左心功能不全治疗56例分析
曲美他嗪治疗冠心病合并左心功能不全的临床疗效
哈尔滨医药(2015年2期)2015-12-01 03:57:18
芪苈强心胶囊治疗心功能不全的效果观察
冠状动脉支架置入后左心功能变化